KFU. Card publication. Tamoxifen suppresses NLRP3 priming via miR-223 in breast cancer independently from ER alpha

KAZAN
FEDERAL UNIVERSITY

- RUS
- 中文
- ES

TAMOXIFEN SUPPRESSES NLRP3 PRIMING VIA MIR-223 IN BREAST CANCER INDEPENDENTLY FROM ER ALPHA

Form of presentation

Articles in international journals and collections

Year of publication

2022

��

��

Authors, employees of KFU

Khamza Shaymaa , author

Bibliographic description in the original language

Hamza Shaimaa, Garanina Ekaterina E., Khaiboullina Svetlana F., Tamoxifen suppresses NLRP3 priming via miR-223 in breast cancer independently from ER alpha//CELL DEATH DISCOVERY. - 2022. - Vol.8, Is.1. - P.2-2.

Keywords

NLRP3; breast cancer; estrogen receptor alpha; mifepristone; progesterone receptor; tamoxifen.

The name of the journal

CELL DEATH DISCOVERY

Please use this ID to quote from or refer to the card

https://repository.kpfu.ru/eng/?p_id=279203&p_lang=2

Full metadata record

Field DC	Value	Language
dc.contributor.author	Khamza Shaymaa	ru_RU
dc.date.accessioned	2022-01-01T00:00:00Z	ru_RU
dc.date.available	2022-01-01T00:00:00Z	ru_RU
dc.date.issued	2022	ru_RU
dc.identifier.citation	Hamza Shaimaa, Garanina Ekaterina E., Khaiboullina Svetlana F., Tamoxifen suppresses NLRP3 priming via miR-223 in breast cancer independently from ER alpha//CELL DEATH DISCOVERY. - 2022. - Vol.8, Is.1. - P.2-2.	ru_RU
dc.identifier.uri	https://repository.kpfu.ru/eng/?p_id=279203&p_lang=2	ru_RU
dc.description.abstract	CELL DEATH DISCOVERY	ru_RU
dc.language.iso	ru	ru_RU
dc.subject		ru_RU
dc.title	Tamoxifen suppresses NLRP3 priming via miR-223 in breast cancer independently from ER alpha	ru_RU
dc.type	Articles in international journals and collections	ru_RU